Pharming Group NV Working Capital to Net Assets Ratio
Pharming Group NV working capital to net assets ratio. Pharming Group NV (PHAR) has a Working Capital to Net Assets ratio of 68.1% as of March 2026. Working capital of $183.16 Million (current assets of $295.51 Million minus current liabilities of $112.35 Million) is measured against net assets of $268.96 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Pharming Group NV tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pharming Group NV (2005–2025)
Working capital to net assets ratio of Pharming Group NV from 2005 to 2025. This chart shows how Pharming Group NV's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 68.1%, reflecting working capital of $183.16 Million against net assets of $268.96 Million USD. See defensive interval ratio of Pharming Group NV to measure how many days the company can operate on defensive assets alone.
Pharming Group NV Working Capital to Net Assets Ratio by Year (2005–2025)
Pharming Group NV working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Pharming Group NV from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Pharming Group NV asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.3% | $183.59 Million | $277.02 Million | $299.38 Million | $115.79 Million | ▼ -26.3 pp |
| 2024 | 92.6% | $204.64 Million | $221.06 Million | $278.44 Million | $73.80 Million | ▼ -16.4 pp |
| 2023 | 109.0% | $238.37 Million | $218.78 Million | $316.34 Million | $77.97 Million | ▲ +2.5 pp |
| 2022 | 106.4% | $217.80 Million | $204.64 Million | $277.50 Million | $59.70 Million | ▲ +1.4 pp |
| 2021 | 105.1% | $202.67 Million | $192.92 Million | $249.44 Million | $46.77 Million | ▲ +3.5 pp |
| 2020 | 101.6% | $152.56 Million | $150.16 Million | $215.47 Million | $62.91 Million | ▲ +97.2 pp |
| 2019 | 4.4% | $5.18 Million | $117.39 Million | $119.44 Million | $114.25 Million | ▼ -48.8 pp |
| 2018 | 53.2% | $37.57 Million | $70.64 Million | $132.05 Million | $94.49 Million | ▼ -104.9 pp |
| 2017 | 158.1% | $35.66 Million | $22.56 Million | $105.87 Million | $70.22 Million | ▲ +118.7 pp |
| 2016 | 39.4% | $11.37 Million | $28.89 Million | $65.41 Million | $54.03 Million | ▼ -118.4 pp |
| 2015 | 157.8% | $41.13 Million | $26.06 Million | $55.86 Million | $14.73 Million | ▲ +43.0 pp |
| 2014 | 114.8% | $41.67 Million | $36.29 Million | $59.76 Million | $18.09 Million | ▼ -118.2 pp |
| 2013 | 233.0% | $16.12 Million | $6.92 Million | $33.97 Million | $17.85 Million | ▲ +226.2 pp |
| 2012 | 6.8% | $-686.38K | $-10.12 Million | $11.17 Million | $11.86 Million | ▲ +429.8 pp |
| 2011 | -423.1% | $6.51 Million | $-1.54 Million | $17.06 Million | $10.54 Million | ▼ -616.8 pp |
| 2010 | 193.7% | $26.02 Million | $13.43 Million | $38.90 Million | $12.88 Million | ▲ +251.5 pp |
| 2009 | -57.8% | $-11.03 Million | $19.07 Million | $40.93 Million | $51.97 Million | ▼ -244.7 pp |
| 2008 | 186.9% | $32.61 Million | $17.45 Million | $50.08 Million | $17.47 Million | ▲ +27.9 pp |
| 2007 | 159.0% | $80.41 Million | $50.58 Million | $114.75 Million | $34.33 Million | ▲ +92.4 pp |
| 2006 | 66.6% | $43.83 Million | $65.78 Million | $55.97 Million | $12.13 Million | ▼ -2.3 pp |
| 2005 | 68.9% | $23.46 Million | $34.04 Million | $30.22 Million | $6.76 Million | — |